';
Policy Areas

The Brain Injury Association of America (BIAA) will be conducting an event via Zoom that will focus on the recent announcement from the Centers for Medicare and Medicaid Services (CMS) that formally designated brain injury as a chronic health condition. The session, “CMS Chronic Condition Designation — What it Means for You,” will be held on September 24, 2024, at 12:00 pm.

Panelists for this event include:

  • Denver Supinger, BIAA’s Director of Advocacy and Government Relations;
  • Karen Kimsey, former Director of the Department of Medical Assistance Services;
  • Paul Bosworth, brain injury survivor and member of BIAA’s Brain Injury Survivors Council; and
  • Darcy Keith, brain injury survivor and member of BIAA’s Brain Injury Survivors Council.

To participate in the event, please register here.

Image by Werner Moser from Pixabay

The Pennsylvania Department of Drug and Alcohol Programs (DDAP), through RCPA, is seeking input on its plan to license telehealth-only outpatient SUD treatment providers.

In an effort to regulate unlicensed, out-of-state telehealth providers marketing themselves as addiction treatment providers as well as expand access, DDAP plans to license telehealth-only outpatient SUD treatment providers. These DDAP-licensed telehealth-only providers may provide intake, evaluation, and referral, as well as outpatient, intensive outpatient, or partial hospitalization services via telehealth only, without a physical plant location in Pennsylvania, to individuals who are located in the Commonwealth as long as the provider complies with all applicable federal, state, and local laws.

DDAP will not require the provider to maintain a physical location in Pennsylvania. DDAP also will grant all telehealth-only providers an exception to §709.11(b) regarding the requirement to conduct an onsite inspection for the renewal of a license as part of licensure.

DDAP has also said licensure is no guarantee of payment. Providers that are considering applying for a telehealth-only license should consult their public and private insurance payers to confirm whether they will meet conditions for network enrollment and payment, as DDAP cannot guarantee a DDAP-licensed telehealth-only provider funding or a contract.

Some providers have raised concerns about:

  • The effectiveness and quality of tele-only treatment without an ability for in-person counseling and how it could harm patients;
  • The siphoning of commercial patients from community-based providers and how it would negatively affect their financial situation;
  • The long-term sustainability of community-based providers who understand their community as large national players enter Pennsylvania; and
  • Maximizing existing outpatient capacity in Pennsylvania.

Comments may be emailed directly to DDAP Deputy Secretary Kelly Primus. Or, by the close of business this Friday, Sept. 20, please submit to RCPA SUD Treatment Services Provider Policy Director Jason Snyder any comments about this plan. RCPA will then share the comments with DDAP. In addition to any concerns you may have about this new license category, please include in your comments any proposed solutions you have about preventing unlicensed telehealth-only outpatient organizations from providing SUD treatment counseling via telehealth in Pennsylvania.

The Office of Developmental Programs (ODP) has shared an updated version of ODPANN 23-083. This bulletin announces the availability and criteria for Needs Group 5 (NG5) residential fee schedule rates and reissues the criteria, process, and procedures for residential fee schedule rate exceptions in the Consolidated Waiver. Please view the announcement for updated information, which has been highlighted red.

The Office of Developmental Programs (ODP) has shared ODPANN 24-064, which notifies Trainers and Learners that the start of the Medication Administration (MA) system upgrade has been delayed. The upcoming system upgrade for the Medication Administration system will be starting Thursday, October 10, 2024, and ending Wednesday, October 23, 2024. Please view the announcement for details. Updates are indicated in red.

October marks National Disability Employment Awareness Month (NDEAM), a time to celebrate and promote inclusive work environments. Join the Office of Developmental Programs (ODP) for an insightful discussion on the history of NDEAM, the Employment First movement, and Pennsylvania’s commitment to advancing inclusive employment opportunities. Discover how Employment First has shaped ODP’s evolving supports and services, empowering individuals with disabilities to secure and sustain competitive, integrated employment, and supporting access to good jobs for everyone.

Audience:
All Stakeholders

Dates:
October 25, 2024
11:00 am – 12:00 pm

Register Here

Photo by Copernico on Unsplash

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) 2024 Emerging Drug Trends Symposium is set for 8:00 am – 3:30 pm Tuesday, November 19, at the Penn Harris Hotel, 1150 Camp Hill Bypass, Camp Hill, PA 17011. The symposium is free to attend, but registration is required.

Attendees will gain a better understanding of:

  • The latest trends in drug use in Pennsylvania;
  • Changes in overdose trends; and
  • Best practices and innovative approaches to respond to emerging drug trends.

Continuing education credits and reduced hotel room rates are available.

DDAP is also accepting proposals for breakout sessions that would address the following topics:

  • Emerging New Drugs of Misuse
  • Emerging Drugs in Schools & Communities
  • Social Media & the Connection to Drug Use
  • Specialty Court Drug Trends
  • Cannabis (including Deltas 8 & 10)
  • Cannabis Legislation
  • Vapes & Vaping Trends
  • Cannabis Vapes
  • Narcotics & Opioids
  • Heroin to Methamphetamines
  • Stash Compartments
  • “To go” Alcohol Trends
  • Underage Drinking/Alcohol Trends
  • Drug Accessibility/Legal Drugs
  • Over-the-Counter Drug Misuse